Cargando…
Computational-based drug repurposing methods in COVID-19
[Image: see text] COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost c...
Autor principal: | Masoudi-Sobhanzadeh, Yosef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416005/ https://www.ncbi.nlm.nih.gov/pubmed/32793443 http://dx.doi.org/10.34172/bi.2020.25 |
Ejemplares similares
-
A fuzzy logic-based computational method for the repurposing of drugs against COVID-19
por: Masoudi-Sobhanzadeh, Yosef, et al.
Publicado: (2022) -
Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021) -
Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm
por: Masoudi-Sobhanzadeh, Yosef, et al.
Publicado: (2020) -
A machine learning method based on the genetic and world competitive contests algorithms for selecting genes or features in biological applications
por: Masoudi-Sobhanzadeh, Yosef, et al.
Publicado: (2021) -
Trader as a new optimization algorithm predicts drug-target interactions efficiently
por: Masoudi-Sobhanzadeh, Yosef, et al.
Publicado: (2019)